MedTrace Logo

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

NCT06348290 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-04-04

No results posted yet for this study

Summary

This is an open-label, non-randomized, clinical study to evaluate the drug interaction between itraconazole, rifampin or Cocktail and JMKX001899 in healthy subjects. A total of three cohorts of 72 healthy subjects were planned to be enrolled in each cohort.

Conditions

  • Solid Tumor, Adult

Interventions

DRUG

JMKX001899

Oral

DRUG

Itraconazole

Oral

DRUG

Midazolam

Oral

DRUG

Rifampin

Oral

DRUG

dextromethorphan

Oral

DRUG

Rosuvastatin

Oral

DRUG

digoxin

Oral

Sponsors & Collaborators

  • Jemincare

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-05-31
Completion
2024-09-15

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06348290 on ClinicalTrials.gov